Aaron Goldberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aaron Goldberg has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Esther Cruijsen
Wageningen University UR, Division of Human Nutrition and Health, Wageningen, Netherlands
1 shared publicationLinda Oude Griep
University of Cambridge, MRC Epidemiology Unit, Cambridge, UK
1 shared publication- Michael Stephen Marber
King's College London BHF Centre, The Rayne Institute, St Thomas' Hospital, London, UK
1 shared publication - Samuel McGrath
King's BHF Centre of Research Excellence, King's College London, London, United Kingdom
1 shared publication Wasiq Sajjad
Barts Health NHS Trust, London, UK
1 shared publication
Latest Publications
- 14 May 2026
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 76 (suppl 1)
Does recommending healthy diets in general practice benefit secondary prevention of cardiovascular disease? A systematic review and meta-analysis
Background: Suboptimal diet is the main preventable risk factor globally for cardiovascular disease (CVD), posing major burden for primary care. However, healthy dietary recommendations’ evidence in patients with established CVD is unclear. Aim: Systematically review and meta-analyse dietary patterns’ effect on CVD patients’ all-cause and CVD mortality, and CVD recurrence. Method: Publication databases were searched for randomised controlled trials (RCTs) (≥6 months follow-up) and prospective cohort studies. Random-effects meta-analysis calculated relative-risks (RR) and 95% confidence-intervals (95% CI). Cochrane bias risk tools assessed study quality. Results: Screening 28 291 abstracts identified 41 articles meeting inclusion criteria. Nineteen articles from 14 unique RCTs conducted 1956–2020, enrolling 14 065 CVD patients, compared fat-replacement, Mediterranean, low-fat, low-sodium, and high-fibre diets with minimal/no dietary advice. Pooled results showed no diet intervention significantly impacted mortality/CVD outcomes. However, stratified meta-analysis revealed a Mediterranean-diet significantly reduced CVD mortality (RR: 0.40; 95% CI: 0.19, 0.83). Twenty-two cohort studies, conducted 1976–2017 for 104 386 CVD patients, predominantly assessed a Mediterranean diet (60%), showing greatest healthy dietary pattern adherence significantly reduced all-cause mortality by 29% (0.71; 0.65, 0.78), CVD mortality by 25% (0.75; 0.66, 0.84), and CVD recurrence by 17% (0.83; 0.75, 0.92). Overall, there was considerable between-study heterogeneity (RCTs: I 2 = 34–60%, cohorts: I 2 = 49–76%) partly explained by disparate geographical locations, and studies were mainly classified as of some concerns (65% RCTs) or high bias risk (52% cohorts). Conclusion: GPs providing healthy dietary advice, particularly the Mediterranean diet, likely enhances CVD secondary prevention. However, cogent studies with clearly defined diets are required to bolster the evidence.
- 14 May 2026
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 76 (suppl 1)
Does recommending healthy diets in general practice benefit secondary prevention of cardiovascular disease? A systematic review and meta-analysis
Background: Suboptimal diet is the main preventable risk factor globally for cardiovascular disease (CVD), posing major burden for primary care. However, healthy dietary recommendations’ evidence in patients with established CVD is unclear. Aim: Systematically review and meta-analyse dietary patterns’ effect on CVD patients’ all-cause and CVD mortality, and CVD recurrence. Method: Publication databases were searched for randomised controlled trials (RCTs) (≥6 months follow-up) and prospective cohort studies. Random-effects meta-analysis calculated relative-risks (RR) and 95% confidence-intervals (95% CI). Cochrane bias risk tools assessed study quality. Results: Screening 28 291 abstracts identified 41 articles meeting inclusion criteria. Nineteen articles from 14 unique RCTs conducted 1956–2020, enrolling 14 065 CVD patients, compared fat-replacement, Mediterranean, low-fat, low-sodium, and high-fibre diets with minimal/no dietary advice. Pooled results showed no diet intervention significantly impacted mortality/CVD outcomes. However, stratified meta-analysis revealed a Mediterranean-diet significantly reduced CVD mortality (RR: 0.40; 95% CI: 0.19, 0.83). Twenty-two cohort studies, conducted 1976–2017 for 104 386 CVD patients, predominantly assessed a Mediterranean diet (60%), showing greatest healthy dietary pattern adherence significantly reduced all-cause mortality by 29% (0.71; 0.65, 0.78), CVD mortality by 25% (0.75; 0.66, 0.84), and CVD recurrence by 17% (0.83; 0.75, 0.92). Overall, there was considerable between-study heterogeneity (RCTs: I 2 = 34–60%, cohorts: I 2 = 49–76%) partly explained by disparate geographical locations, and studies were mainly classified as of some concerns (65% RCTs) or high bias risk (52% cohorts). Conclusion: GPs providing healthy dietary advice, particularly the Mediterranean diet, likely enhances CVD secondary prevention. However, cogent studies with clearly defined diets are required to bolster the evidence.
- Open Access
- 20 June 2025
- Published by MDPI AG in Medical Sciences Forum
- Vol. 32 (1) , 3
Improving Bone Protection Provision for Patients with Fragility Fractures
Osteoporosis therapy is a crucial component of fragility fracture patients’ care. A Quality Improvement Project (QIP) was undertaken to review and improve such bone protection practice within a busy UK hospital orthopaedic department. Full-loop audit cycles, totalling 216 patients, were conducted before and after the implementation of a single-page checklist. This intervention significantly increased consultant-led osteoporosis plans by 37%, enhanced bone-sparing treatment administration by 20%, and eliminated unsafe prescriptions. Provision timeliness was not affected, but the communication of correct discharge information was significantly improved by 27%, and staff surveys showed the checklist was well-received, easy-to-use, and educational. Hopefully this will encourage other orthogeriatric teams to utilise a similarly effective and simple QI strategy.
- 20 June 2025
- Published by MDPI AG in Medical Sciences Forum
- Vol. 32 (1) , 3
Open AccessImproving Bone Protection Provision for Patients with Fragility Fractures
Osteoporosis therapy is a crucial component of fragility fracture patients’ care. A Quality Improvement Project (QIP) was undertaken to review and improve such bone protection practice within a busy UK hospital orthopaedic department. Full-loop audit cycles, totalling 216 patients, were conducted before and after the implementation of a single-page checklist. This intervention significantly increased consultant-led osteoporosis plans by 37%, enhanced bone-sparing treatment administration by 20%, and eliminated unsafe prescriptions. Provision timeliness was not affected, but the communication of correct discharge information was significantly improved by 27%, and staff surveys showed the checklist was well-received, easy-to-use, and educational. Hopefully this will encourage other orthogeriatric teams to utilise a similarly effective and simple QI strategy.
- Open Access
- 12 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7570
How Close Are We to Patient-Side Troponin Testing?
Laboratory-based high-sensitivity cardiac troponin testing has been the pillar for emergency stratification of suspected acute coronary syndrome for well over a decade. Point-of-care troponin assays achieving the requisite analytical sensitivity have recently been developed and could accelerate such assessment. This review summarises the latest assays and describes their potential diverse clinical utility in the emergency department, community healthcare, pre-hospital, and other hospital settings. It outlines the current clinical data but also highlights the evidence gap, particularly the need for clinical trials using whole blood, that must be addressed for safe and successful implementation of point-of-care troponin analysis into daily practice. Additionally, how point-of-care troponin testing can be coupled with advances in biosensor technology, cardiovascular screening, and triage algorithms is discussed.
- 12 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7570
Open AccessHow Close Are We to Patient-Side Troponin Testing?
Laboratory-based high-sensitivity cardiac troponin testing has been the pillar for emergency stratification of suspected acute coronary syndrome for well over a decade. Point-of-care troponin assays achieving the requisite analytical sensitivity have recently been developed and could accelerate such assessment. This review summarises the latest assays and describes their potential diverse clinical utility in the emergency department, community healthcare, pre-hospital, and other hospital settings. It outlines the current clinical data but also highlights the evidence gap, particularly the need for clinical trials using whole blood, that must be addressed for safe and successful implementation of point-of-care troponin analysis into daily practice. Additionally, how point-of-care troponin testing can be coupled with advances in biosensor technology, cardiovascular screening, and triage algorithms is discussed.